Table 1.
Panel of 31 basal cell carcinoma cases.
| p53 | Survivin | Diagnosis -subtype | Age | Sex | |||||
|---|---|---|---|---|---|---|---|---|---|
| I | P (%) | s. l. | I | P (%) | s. l. | ||||
| 1. | ++ | >25 | N | ++ | <25 | NC | Micronodular | 54 | M |
| 2. | + | >25 | N | + | <25 | NC | Cystic pigmented | 79 | M |
| 3. | ++ | >25 | N | + | <25 | NC | Solid | 50 | F |
| 4. | +++ | >25 | NC | + | <25 | NC | Multicentric | 53 | M |
| 5. | ++ | >25 | N | + | >25 | NC | Multicentric | 61 | M |
| 6. | ++ | >25 | N | ++ | <25 | NC | Multicentric | 82 | F |
| 7. | +++ | >25 | N | + | <25 | NC | Cystic | 84 | M |
| 8. | ++ | >25 | NC | ++ | <25 | NC | Mixed form | 79 | F |
| 9. | ++ | >25 | N | + | <25 | NC | Cystic | 77 | F |
| 10. | ++ | >25 | N | + | <25 | NC | Multicentric | 56 | F |
| 11. | ++ | >25 | N | + | <25 | NC | Solid | 50 | M |
| 12. | ++ | >25 | N | + | <25 | NC | Cystic | 88 | M |
| 13. | ++ | >25 | N | + | >25 | NC | Solid | 57 | M |
| 14. | ++ | >25 | N | ++ | <25 | NC | Cystic | 72 | M |
| 15. | + | >25 | N | + | <25 | NC | Mixed | 64 | M |
| 16. | ++ | >25 | N | + | <25 | NC | Multicentric | 31 | F |
| 17. | ++ | >25 | N | + | <25 | NC | Cystic | 78 | M |
| 18. | + | >25 | N | + | <25 | NC | Multicentric | 84 | M |
| 19. | + | >25 | N | 0 | – | – | Multicentric | 52 | M |
| 20. | ++ | >25 | N | 0 | – | – | Cystic | 53 | M |
| 21. | + | >25 | NC | + | <25 | NC | Solid | 78 | M |
| 22. | + | >25 | N | + | <25 | NC | Solid | 87 | F |
| 23. | ++ | >25 | N | + | <25 | NC | Multicentric | 39 | M |
| 24. | ++ | >25 | N | + | <25 | NC | Multicentric | 68 | M |
| 25. | ++ | >25 | NC | + | <25 | NC | Adenoid-cystic | 75 | F |
| 26. | ++ | >25 | N | ++ | <25 | NC | Solid | 79 | M |
| 27. | + | <25 | NC | + | <25 | NC | Multicentric | 71 | M |
| 28. | + | <25 | N | + | <25 | N | Mixed form | 78 | M |
| 29. | 0 | – | – | 0 | – | – | Cystic | 72 | F |
| 30. | 0 | – | – | 0 | – | – | Cystic | 70 | F |
| 31. | 0 | – | – | + | <25 | NC | Cystic | 59 | M |
I – intensity of immunoreactivity: 0 – no positivity, s. l. – subcellular localization of survivin and p53; + mild, ++ moderate, +++ strong; C – cytoplasm positivity; P – percentage of labeled cells; N – nuclear positivity; NC – nuclear as well as cytoplasmic positivity.